- Home
- CSGP vs BNTX Comparison
CSGP vs BNTX Comparison
Compare CSGP & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSGP | BNTX |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.1B | 22.8B |
| IPO Year | 1998 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CSGP | BNTX |
|---|---|---|
| Price | $36.15 | $95.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 13 |
| Target Price | $74.77 | ★ $133.38 |
| AVG Volume (30 Days) | ★ 5.3M | 886.3K |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $965,230,000.00 | N/A |
| Revenue This Year | $19.71 | N/A |
| Revenue Next Year | $12.40 | $4.98 |
| P/E Ratio | $1,863.50 | ★ N/A |
| Revenue Growth | ★ 15.23 | N/A |
| 52 Week Low | $36.91 | $79.81 |
| 52 Week High | $97.43 | $124.00 |
Technical Indicators
Market Signals| Indicator | CSGP | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 25.73 | 54.91 |
| Support Level | N/A | $95.13 |
| Resistance Level | $69.64 | $114.06 |
| Average True Range (ATR) | 1.84 | 2.44 |
| MACD | -0.10 | 1.34 |
| Stochastic Oscillator | 7.89 | 96.70 |
Price Performance
Historical ComparisonAbout CSGP CoStar Group Inc.
CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors spanning office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many well-respected brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence into Canada, the United Kingdom, Spain, and France.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.